Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma
2022 · Journal of Experimental & Clinical Cancer Research · 34 citations
https://doi.org/10.1186/s13046-022-02401-6
Y
Ying Tang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
1.6K
Citations
23
h-index
31
i10-index
Ying Tang is an academic researcher from Chongqing Technology and Business University. The author has contributed to research in topics: RNA modifications and cancer & Epigenetics and DNA Methylation & Microbial Natural Products and Biosynthesis. The author has an h-index of 23, co-authored 68 publications.
ORCID: 0000-0002-1582-645XPapers by this author
worksAdvancements and challenges in CAR-T cell therapy for solid tumors: A comprehensive review of antigen targets, strategies, and future directions
2025 · Cancer Cell International · 10 citations
https://doi.org/10.1186/s12935-025-03938-0
Hypoxia-sensitive cells trigger NK cell activation via the KLF4-ASH1L-ICAM-1 axis, contributing to impairment in the rat epididymis
2023 · Cell Reports · 4 citations
https://doi.org/10.1016/j.celrep.2023.113442
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat